Companies/Exagen Inc.

Company profile

Exagen Inc.

NASDAQ: XGN · Healthcare · Medical - Diagnostics & Research

PublicHQ Vista, CA · San DiegoCIK 0001274737Reports USD

#396 of 1,394 Healthcare companies by revenue66th-percentile growth

EA Score

55C

FH 49DQ 55GM 71SS 57

v0.1 · 65/100 weight · provisional

↑ growth stability, workforce scale · ↓ return on equity, listing tenure

Methodology →

Revenue TTM

$68.4M

Rev growth YoY (TTM)

+20.6%

Net income (FY)

-$20.0M

Employees

209

Market cap

$109.7M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$66.6M$66.6M2025

Net income-$20.0M-$20.0M2025

Operating income-$14.1M-$14.1M2025

Total assets$58.0M$58.0M2025

Liabilities$40.6M$40.6M2025

Equity$17.4M$17.4M2025

Revenue trend

FY2019 – FY2025 · USD

$32.4M

FY19

$40.4M

FY19

$42.0M

FY20

$48.3M

FY21

$45.6M

FY22

$52.5M

FY23

$55.6M

FY24

$66.6M

FY25

Revenue by segment

Filed disclosures · FY2025

By product

Reportable100%

By geography

Not disclosed.

The read

Exagen Inc. booked $66.6M in FY2025 revenue, growing 20% year over year — faster than most Healthcare companies we track, at a -30.0% net margin.

Peers · Healthcare

Hyperfine, Inc.44D QT Imaging Holdings, Inc.40D Lucid Diagnostics Inc.35D Anixa Biosciences, Inc.52D

Neighbors

San Diego →

QUALCOMM Incorporated$44.3B79B+Sempra$12.4B64C Realty Income Corporation$5.7B59C ResMed Inc.$5.1B88A Illumina, Inc.$4.3B84B+DexCom, Inc.$4.7B87A

Key facts

CEOJohn Aballi

SectorHealthcare

IndustryMedical - Diagnostics & Research

HeadquartersVista, CA

ExchangeNASDAQ: XGN

Employees209

IPO date2019-09-19

Latest filings

8-K2026-06-09 8-K2026-05-11 10-Q2026-05-11 DEF 14A2026-04-27 8-K2026-04-23 8-K2026-03-10 10-K2026-03-10 8-K2026-01-12

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.